Neurology ReviewsPatients Want the Facts Delivered in a Personal StoryFebruary 21, 2024Business of Medicine
Neurology ReviewsBiogen’s Abandonment of Controversial Alzheimer’s Drug Is No Surprise, Experts SayFebruary 6, 2024Alzheimer's & CognitionBusiness of Medicine
Neurology ReviewsFirst Impressions and Lessons LearnedFebruary 6, 2024Business of MedicineDiversity in Medicine
Neurology ReviewsMega Malpractice Verdicts Against Physicians on the RiseFebruary 2, 2024Business of Medicine
Neurology ReviewsUS Board Discloses Cheating, Grads Say Problem Is RampantFebruary 1, 2024Business of Medicine
Neurology ReviewsDoctors With Limited Vacation Have Increased Burnout RiskJanuary 30, 2024Business of Medicine
Neurology ReviewsVA Versus the Private Sector — No Contest? Think AgainJanuary 29, 2024Business of Medicine
Neurology ReviewsDana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid AllegationsJanuary 25, 2024Business of Medicine
Neurology ReviewsA Healthy Dose of SuperstitionJanuary 23, 2024Business of MedicineAlzheimer's & Cognition
